Dry Eye Syndrome Treatment Market Overview, Analysis, Impact of Coronavirus (COVID-19) Pandemic

 

Dry Eye Syndrome Treatment

People with autoimmune disorders or other systemic ailments such as diabetes, Parkinson's disease, rosacea, rheumatoid arthritis, systemic lupus erythematosus, sarcoidosis, Sjögren syndrome, and thyroid disease are at risk for dry eye syndrome. Furthermore, dry eyes might occur as a result of difficulties with inflammation of the eyelids (blepharitis) or the surfaces of the eye. Antihistamines, antidepressants, decongestants, and blood pressure drugs, among others, can lower tear production, resulting in dry eye symptoms.

According to Coherent Market Insights, The global Dry Eye Syndrome Treatment Market is estimated to be valued at US$ 5,382.6 Million in 2020 and is expected to exhibit a CAGR of 16.2% during the forecast period (2020-2027). People who spend a lot of time in front of a computer or a screen are at a higher risk of having dry eyes, since prolonged usage of a screen reduces blinking and tear production. Due to widespread use for social and professional purposes, digital gadget usage has expanded dramatically among all age groups in recent years.

People who spend a lot of time in front of a computer or a screen are at a higher risk of having dry eyes, since prolonged usage of a screen reduces blinking and tear production. Due to widespread use for social and professional purposes, digital gadget usage has expanded dramatically among all age groups in recent years.

Dry eye illness affects a large percentage of the worldwide population (from middle age to elderly age). Women are more likely than males to get the condition. According to the World Ageing 2020 estimate, there will be 727 million people aged 65 and more in the year 2020. In 2050, this population is expected to increase to 1.5 billion. From 9.3 percent in 2020 to roughly 16.0 percent in 2050, the proportion of the population aged 65 and up is predicted to rise. The older population is expected to grow, and this group is more susceptible to eye-related ailments including dry eye, which will drive the market forward in the near future.

Dry Eye Syndrome Treatment Market restraints-

The lack of access to eye care facilities in poor and middle-income countries, as well as the restriction of existing treatment methods to primary care practitioners, are some of the factors leading to the paucity of dry eye disease therapy. According to the University of Calabar in Nigeria, the biggest impediments to eye care in the nation include high treatment costs, a scarcity of educated practitioners, and a lack of public knowledge about eye care. Furthermore, some people regard dry eye as a symptom rather than an illness, and so overlook the necessity of early detection and treatment to avoid the development of chronic ocular surface disease.

Impact of Coronavirus (Covid-19) Pandemic on Dry Eye Syndrome Treatment Market-

COVID-19 has the potential to impact the economy in three ways: directly impacting production and demand, causing distribution channel disruptions, and having a financial impact on enterprises and financial markets. Several nations, including China, India, Saudi Arabia, the United Arab Emirates, Egypt, and others, are experiencing difficulties transporting medications from one location to another as a result of the shutdown. Due to the COVID-19 pandemic, players in the Dry Eye Syndrome Treatment Market are facing substantial difficulties on several fronts. The availability of raw materials for producing medication formulations is a serious concern because to transportation facility inconsistencies. Furthermore, medicinal product wholesalers are encountering fluctuating demand from retailers.